These medications offer substantial weight reductionoften 15-20% of body weightraising important questions about their safety and efficacy specifically in patients with fatty liver disease
Among the RCTs, one study had some concerns due to the randomization process [20], while another exhibited some concerns in the intervention domain [30]
Interfacial Electrostatic Scaffold: A concept of interfacial electrostatic scaffold is proposed, involving multiple salt bridges at the binding interface to enhance the stability and binding affinity of the semaglutide analogue to GLP-1R ECD
Table 1 Characteristics of included studies on GLP-1 receptor agonists in gestational diabetes mellitus
If an employee remains out longer than that, the government assumes responsibility for covering the benefits
Macpherson K, Cooper K, Harbour J, Mahal D, Miller C, Nairn M